Show simple item record

dc.contributor.authorAzman, AS
dc.contributor.authorParker, LA
dc.contributor.authorRumunu, J
dc.contributor.authorTadesse, F
dc.contributor.authorGrandesso, F
dc.contributor.authorDeng, LL
dc.contributor.authorLino, RL
dc.contributor.authorBior, BK
dc.contributor.authorLasuba, M
dc.contributor.authorPage, AL
dc.contributor.authorOntweka, L
dc.contributor.authorLlosa, AE
dc.contributor.authorCohuet, S
dc.contributor.authorPezzoli, L
dc.contributor.authorSodjinou, DV
dc.contributor.authorAbubakar, A
dc.contributor.authorDebes, AK
dc.contributor.authorMpairwe, AM
dc.contributor.authorWamala, JF
dc.contributor.authorJamet, C
dc.contributor.authorLessler, J
dc.contributor.authorSack, DA
dc.contributor.authorQuilici, ML
dc.contributor.authorCiglenecki, I
dc.contributor.authorLuquero, FJ
dc.date.accessioned2016-11-06T13:25:43Z
dc.date.available2016-11-06T13:25:43Z
dc.date.issued2016-11-01
dc.identifier.citationEffectiveness of One Dose of Oral Cholera Vaccine in Response to an Outbreak: A Case-Cohort Study. 2016, 4 (11):e856-e863 Lancet Glob Healthen
dc.identifier.issn2214-109X
dc.identifier.pmid27765293
dc.identifier.doi10.1016/S2214-109X(16)30211-X
dc.identifier.urihttp://hdl.handle.net/10144/618692
dc.description.abstractOral cholera vaccines represent a new effective tool to fight cholera and are licensed as two-dose regimens with 2-4 weeks between doses. Evidence from previous studies suggests that a single dose of oral cholera vaccine might provide substantial direct protection against cholera. During a cholera outbreak in May, 2015, in Juba, South Sudan, the Ministry of Health, Médecins Sans Frontières, and partners engaged in the first field deployment of a single dose of oral cholera vaccine to enhance the outbreak response. We did a vaccine effectiveness study in conjunction with this large public health intervention.
dc.languageENG
dc.language.isoenen
dc.publisherElsevieren
dc.rightsArchived with thanks to The Lancet. Global healthen
dc.titleEffectiveness of One Dose of Oral Cholera Vaccine in Response to an Outbreak: A Case-Cohort Studyen
dc.identifier.journalThe Lancet. Global healthen
refterms.dateFOA2019-03-04T12:56:56Z
html.description.abstractOral cholera vaccines represent a new effective tool to fight cholera and are licensed as two-dose regimens with 2-4 weeks between doses. Evidence from previous studies suggests that a single dose of oral cholera vaccine might provide substantial direct protection against cholera. During a cholera outbreak in May, 2015, in Juba, South Sudan, the Ministry of Health, Médecins Sans Frontières, and partners engaged in the first field deployment of a single dose of oral cholera vaccine to enhance the outbreak response. We did a vaccine effectiveness study in conjunction with this large public health intervention.


Files in this item

Thumbnail
Name:
Azman A et al - 2016 - Effecti ...
Size:
307.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record